TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ERSANA

OncologyGastroenterology
Generics

ERSANA is a generic drug manufacturer focused on Oncology, Gastroenterology.

1979
Since
2
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 86%
0 drugs Phase 3: 1 Phase 1: 8
Gastroenterology 14%
0 drugs Phase 1: 2

Pipeline Strength Pro

Loading...